Skip to search formSkip to main contentSkip to account menu

Estracyt

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryThe pharmacokinetics of estramustine phosphate (EMP) was studied in five prostatic cancer patients given single i.v. and… 
Highly Cited
1983
Highly Cited
1983
A prospective trial from July 1976 to September 1980 by the National Prostatic Cancer Project randomized newly diagnosed… 
1981
1981
Plasma concentrations of estramustine phosphate and its major metabolites were measured in patients with prostatic carcinoma… 
Highly Cited
1980
Highly Cited
1980
Two hundred and twelve patients treated for prostatic cancer grade I or II were investigated for cardiovascular complications… 
1980
1980
81 patients with advanced prostate carcinoma, mainly estrogen resistant, were treated with Estracyt. After a pilot study had… 
Highly Cited
1977
Highly Cited
1977
Estramustine phosphate (Estracyt) was used in the treatment of 154 patients with carcinoma of the prostate in stage IV. Sixty… 
1976
1976
Estraumustine phosphate (estradiol, 3-N-[bis(2-chloroethyl)-] carbamate-17beta-dihydrogenphosphate (Estracyt) labeled with 3H in… 
Highly Cited
1971
Highly Cited
1971
Sixty-five patients with advanced prostatic carcinoma that had not responded to conventional therapy were treated with Estracyt…